Ibex Medical Analytics vs Tempus Digital Pathology
Ibex Medical Analytics and Tempus Digital Pathology both compete in pathology, but answer different questions. Ibex Medical Analytics is our pick for deployed globally: Most-deployed AI pathology platform globally. Tempus Digital Pathology earns the Paige acquisition (Aug 2025) slot: Paige Predict 123-biomarker pan-cancer suite, now part of Tempus AI. The right choice depends on whether your priority is deployed globally or paige acquisition (aug 2025).
- Pathology
- 02
- May 23, 2026
Tempus Digital Pathology
by Tempus AI
Paige Predict 123-biomarker pan-cancer suite (Tempus acquired Paige 2025).
- Enterprise + per-test.
- FDA 510(k) / CE-IVDR
How Ibex Medical Analytics and Tempus Digital Pathology compare
Pricing, compliance, and integrations sourced from vendor documentation. Verified May 23, 2026.
| Spec | Ibex Medical Analytics | Tempus Digital Pathology |
|---|---|---|
| Pricing | Enterprise. | Enterprise + per-test. |
| Free tier | Yes | Yes |
| HIPAA | No / unverified | No / unverified |
| SOC 2 Type II | No / unverified | No / unverified |
| EHR integrations | Not specified | Not specified |
| Founded | — | — |
| HQ | IL | US |
| Best for | Best deployed globally | Best after Paige acquisition (Aug 2025) |
Scroll horizontally to see both columns.
When to pick each one
Best deployed globally
Most-deployed AI pathology platform globally.
- Israeli-origin
- Prostate, breast, colon focus
- Broad EU + US deployments
Best after Paige acquisition (Aug 2025)
Paige Predict 123-biomarker pan-cancer suite, now part of Tempus AI.
- NASDAQ:TEM
- Most clinical-validation depth
- FDA + CE-IVDR cleared modules
Open the full pathology comparison
Digital pathology workflows with FDA-cleared cancer detection (prostate, breast, colon), IHC scoring (HER2, Ki67), and AI-powered image management. Tempus, PathAI, Proscia dominate.
/best-ai-pathology